GLP 1 based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP 1 production and L cell differentiation Diabetology & Metabolic Syndrome Springer Nature Link GLP 1 is a naturally occuring hormone. The medications are synthetic GLP 1 receptor agonists, engineered molecules designed to bind to and activate the same receptor that the natural hormone uses and mimic its Glutazumab, a novel long lasting GLP 1 anti GLP 1R antibody fusion protein, exerts anti diabetic effects through targeting dual receptor binding sites ScienceDirect GLP 1 Agonists and Orthopedic Surgery: A Review of Their Impact on Bone Metabolism, Wound Healing, and Surgical Outcomes AOAO